Back to results
US 6,184,357 B2Granted
Prostate-specific kallikrein
AssigneeIncyte Pharmaceuticals, Inc.
InventorsOlga Bandman, Surya K. Goli
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeIncyte Pharmaceuticals, Inc.
InventorsOlga Bandman, Surya K. Goli
Estimating the term…
The present invention provides a human prostate-specific kallikrein (HPSK) and polynucleotides which identify and encode HPSK. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding HPSK and a method for producing HPSK. The invention also provides for agonists, antibodies, or antagonists specifically binding HPSK, and their use, in the prevention and treatment of diseases associated with the expression of HPSK. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding HPSK for the treatment of diseases associated with the expression of HPSK. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding HPSK.
A purified antibody which binds specifically to a polypeptide comprising the amino acid sequence of SEQ ID NO:1.
Dependencies are inferred from the claim text.